Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
CITIC Securities International MTN program update and $600 million drawdown
The floating-rate notes are due 2028
Verisk $1.5 billion senior notes offering
We advised Verisk on the investment-grade notes offering
Kyivstar Group de-SPAC transaction
The transaction resulted in Ukraine’s leading digital operator becoming a U.S.-listed public company
Match Group $700 million senior notes offering
The high-yield notes are due 2033
CHC Group $550 million senior secured notes offering
The high-yield notes are due 2030
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Travel + Leisure $500 million senior secured notes offering
The high-yield notes are due 2033
NXP $1.5 billion senior notes offering
The investment-grade notes are due 2028, 2032 and 2035
PetSmart $2.7 billion notes offering
The high-yield notes are due 2032 and 2033
Centrus Energy $805 million convertible senior notes offering
The 0% convertible senior notes are due 2032